
Work Here?
Weave provides a patient communication platform for dental and optometry practices. It helps small and mid-size healthcare providers manage patient interactions through an integrated SaaS suite that includes appointment scheduling, reminders, two-way texting and calling, patient reviews, and remote features like a virtual waiting room. The product works by offering these tools in a subscription-based service, with different pricing tiers based on practice size and feature needs, so clinics can smoothly run daily operations and engage patients across channels. Weave differentiates itself by delivering an all-in-one communications solution tailored specifically to dental and optometry offices, including remote communication options to support social distancing. The company’s goal is to improve operational efficiency, boost patient engagement, and drive revenue growth for its clients by providing reliable, continuous updates and support.
Industries
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Lehi, Utah
Founded
2008
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$159.6M
Below
Industry Average
Funded Over
9 Rounds
Remote Work Options
Hybrid Work Options
Marketplace movers: August 2026. In August on the athenahealth marketplace, 124 companies added customers, 39 lost them, and 384 held flat. That works out to roughly 3.2 gainers for every decliner, and a net gain of 383 customer connections across the marketplace. Phreesia didn't have a big single day change this month, unlike the past couple of months, so no asterisk on the headline number. Most customers added. Weave takes the top spot for the first time. It's the third month in a row they've shown up on this list. In May they had 7 customers, in June 32, in July 62, and now in August 91. Incredible run. Integrating a technology every practice has (the phone) with the SaaS solution the person is looking at when they answer the phone (athena) seems to be just what practices want. Fullscript is on this list for the fourth time in five months. 735 customers now. Steady growth on the biggest base of any partner in the top five. It is free to the practice, has a simple workflow, and depending on configuration it makes the practice money. I expect their growth to continue. Aledade matched their June number exactly, +17. They added 700 primary care organizations to their network for the 2026 performance year and are now serving one in five new MSSP participants nationally. athena keeps promoting ACO partnerships, and Aledade is a popular choice for an independent practice that wants to do VBC. Zocdoc is 12 customers away from 1,000 connections. It is their third time on this list since May. I called it a blip in May and a fundamental change in June. At this point it's a trend. They are running a national TV campaign this year. Seems likely the customer experience is better than what the reviews say. Suki AI added 14 customers for their ambient scribe. Full disclosure: Suki is a past client of mine. They were named athena's Preferred Solution Partner for ambient intelligence in January. Practices can also get Suki through athena's Ambient Notes product, which doesn't register as a marketplace connection. The 616 here undercounts their athena footprint. Fastest growth. Weave led the Marketplace on percentage too. See above. ReactDx grew 23.1% with their remote cardiac monitoring and home sleep test ordering. They started with 13 practices, helping boost their percentage jump. Med device testing companion apps having been increasing in popularity, a trend that seems likely to continue. Talkie.ai added 7 customers to reach 42. They've been on the AI voice list I've been tracking since June and were one of the fastest-growing partners in Q2. On August 27 they announced they're an approved vendor for Privia Health. Privia is one of the largest athena shops in the country, so if that approval turns into practice adoption, Alsgaard-Miller LLC'll see it in these numbers. ConnectivityWise is a new one to me They connect point-of-care instruments to athena so results file to the chart automatically instead of a medical assistant typing them in. athena offered a version this functionality with specific manufactures over a decade ago. With all the interop options athena offers today, it makes sense a marketplace parter would fill this need. Babyscripts added 2 customers for their OB remote patient monitoring platform. Small base, but they've been at this since 2013 and have raised over $40M doing it. With the upcoming change by CMS to unbundle the global OB billing code and changing RPM rules over the next two years, OB practices will need something exactly like this, and the marketplace has very few options in the category. Methodology. Customer counts pulled from the athena marketplace between August 3 and September 1. Starting this month, the summary numbers collapse mirrored listings (two listings from the same company that have mirrored practice counts) the same way the rankings do. July's net gain would have been +582 under this rule. Minimum starting base of 10 customers to qualify for the rankings. Want a deeper read on a specific category or partner? That's what I do for clients.
Weave supports amspa Members as Platinum Vendor Affiliate. September 8, 2026 Weave has renewed its collaboration with the American Med Spa Association (AmSpa) as a Platinum Vendor Affiliate. Weave is a leading AI-powered patient communications and payment platform purposed-built for medical aesthetics professionals. Operating at the center of patient interactions, Weave brings together AI agent and staff conversations across voice and text into unified, intelligent workflows that power the entire patient journey. Weave reduces administration burden and delivers real-time insights that help businesses run smarter and grow with confidence. AmSpa Members receive a discount of 10% off a month (additional 10% off if paid annually), 1 free month, and $500 activation fee (saving $1,450 on activation).
Weave Communications, Inc. (“Weave”) (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, and ...
Francisco Partners has agreed to acquire Weave Communications, a healthcare-focused patient engagement and payments platform, for approximately $650 million. Shareholders will receive $7.40 per share in cash, representing a 34% premium to the closing price on 17 August 2026. Weave, founded in 2008, serves over 40,000 healthcare practice locations with its AI-powered software platform. The company will remain headquartered in Lehi, Utah, and continue operating under the Weave name after becoming private. The transaction requires shareholder approval and regulatory clearances. It is expected to close in the fourth quarter of 2026. Weave's board unanimously approved the deal following a review of strategic alternatives. Francisco Partners plans to invest in Weave's AI capabilities and expand its payments and revenue cycle management offerings.
Weave (WEAV) to be acquired by Francisco Partners for $7.40 per share. Weave Communications enters a definitive take-private deal with Francisco Partners at $7.40 per share, implying an equity value of roughly $650 million. Stockholders must approve the transaction. Weave Communications WEAV+1.76(+31.83%) surged 8.96% to $7.30 on August 18, 2026 after the company confirmed it has signed a definitive agreement to be acquired by Francisco Partners at $7.40 per share in cash. The all-cash deal implies an equity value of roughly $650 million. The transaction will take WEAV private pending approval from stockholders and customary regulatory clearances. Investors can follow the latest M&A developments on the Market News hub. What happened. Francisco Partners, a private equity firm with a track record of software and technology acquisitions, agreed to acquire 100% of Weave Communications at $7.40 per share. The consideration is entirely cash, removing equity risk for existing holders. Weave reported quarterly earnings on August 6, 2026, posting EPS of $0.04 in line with estimates and revenue of $67.54 million, narrowly missing the $67.88 million consensus estimate. WEAV opened at $7.29 on August 18 and touched $7.30 with approximately 16.1 million shares changing hands. The stock last traded near $6.70 before the announcement. At the offer price, Francisco Partners is paying a modest premium to the pre-news close, reflecting Weave's market position in customer communications software for small and medium-sized healthcare and service businesses. The company employs roughly 854 people and operates primarily in the United States and Canada. The definitive merger agreement contains standard deal protections including a go-shop provision (if applicable) and representations/warranties typical for take-private transactions of this size. No specific closing timeline was disclosed in the initial disclosure. Why it matters. The acquisition removes a publicly traded small-cap software name from the market at a moment when the stock was trading below its 52-week high. For current stockholders, the $7.40 per share offer provides a known exit price, though the premium to the pre-announcement close is modest given Weave's recent business development activity including enterprise AI receptionist features launched in Q2 2026. For acquirers like Francisco Partners, Weave's platform serving SMB front-office workflows in healthcare represents a consolidating asset in a niche vertical. Private equity buyers have been active in acquiring profitable or near-profitable SaaS businesses trading at discounted multiples following the 2022-2024 valuation correction. The $650 million price tag values WEAV at approximately 2.4x trailing quarterly revenue run rate, a reasonable multiple for a cash-generative communications platform. The deal also illustrates continued private equity appetite for healthcare-adjacent technology platforms. Weave's authorized integration ecosystem with electronic health record vendors such as Elation Health gives Francisco Partners a recurring-revenue moat to leverage post-privatization. What to watch next. Stockholders should monitor for the filing of an SEC Schedule 14A proxy statement outlining the deal terms, board recommendations, and shareholder meeting date. The proxy vote is the primary near-term catalyst before closing. Any regulatory review from the FTC or DOJ could introduce timeline uncertainty, particularly given Weave's healthcare data touchpoints. If the deal is expected to close within the next 60 to 90 days, a Form 8-K disclosure confirming proxy mailing would be expected. Watch for unusual options activity in WEAV as dealers hedge around the $7.40 strike ahead of the vote.
Find jobs on Simplify and start your career today
Industries
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Lehi, Utah
Founded
2008
Find jobs on Simplify and start your career today